IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS
IN NCM 102 RLE
CASE STUDY
ECLAMPSIA
SUBMITTED TO:
GREMMA W. BARATAS, RN, MN
CLINICAL INSTRUCTOR
SUBMITTED BY:
JAN FRANCIS D. ALBERO, ST. N
EPHRAIM FRITZ Z. BAWA-AN, ST. N
MA. TRICIA JOY CONSOL B. FANO, ST. N
FRANCIS JOHN GANDEZA, ST. N
FARDEJAH MAISA L. KASUYO, ST. N
ALICIA MAY T. MEDIDA, ST. N
DIRK LOWELL G. REBOSURA, ST. N
KYLES YFTACH F. TEOROSEO, ST. N
DATE SUBMITTED:
MARCH 3, 2016
TABLE OF CONTENTS
I. INTRODUCTION....................................................................................................1-2
A. Background of the study.........................................................................................1
B. Significance of the study.........................................................................................2
C. Relevance of the study...........................................................................................2
II. OBJECTIVES(General and Specific objectives) .................................................3-4
III. HEALTH HISTORY.................................................................................................5
IV. PATIENT PROFILE.................................................................................................5
V. DEVELOPMENTAL TASK....................................................................................6-7
VI. GENERAL ASSESSMENT..................................................................................8-9
VII. ANATOMY AND PHYSIOLOGY....................................................................10-12
VIII. DEFINITION OF TERMS...............................................................................13-14
IX. ETIOLOGY............................................................................................................15
X. PATHOPHYSIOLOGY......................................................................................16-18
XI. PROGNOSIS........................................................................................................19
XII. SYMPTOMATOLOGY....................................................................................20-22
XIII. MEDICAL AND SURGICAL TREATMENT...................................................23-26
XIV. DIAGNOSTIC TEST (LABORATORY TEST)...............................................26-32
XV. NCP................................................................................................................33-35
XVI. DISCHARGE PLANNING (METHOD)..........................................................36-37
A. Medication............................................................................................................36
B. Exercise................................................................................................................37
C. Treatment..............................................................................................................37
D. Health Teaching....................................................................................................37
E. Out-patient order...................................................................................................37
F. Diet........................................................................................................................37
XVII. RECOMMENDATIONS.....................................................................................38
XVIII. BIBLIOGRAPHY/REFERENCES....................................................................39
INTRODUCTION
A. BACKGROUND OF THE STUDY
Hypertensive disorders are the most common medical complication of pregnancy,
affecting 6% to 8% of all pregnancies.1 Approximately 30% of hypertensive disorders in
pregnancy are caused by chronic hypertension, and 70% are caused by gestational
hypertension. The spectrum of disease ranges from mildly elevated blood pressures
(BP) with minimal clinical significance to severe hypertension and multiorgan
dysfunction. The incidence of disease is dependent on many different demographic
parameters, including maternal age, race, and associated underlying medical
conditions. Although geographic and racial differences in incidence have been reported,
several risk factors have been identified as predisposing to the development of
preeclampsia in different populations. For patients with a twin gestation, the incidence
and severity are higher than in those with singleton pregnancy.2 In addition, the
incidence is significantly higher in patients with previous preeclampsia and in those with
previous preeclampsia remote from term.3 Patients older than age 35 years also have
an increased incidence of preeclampsia, mainly because of increased undiagnosed
chronic hypertension in this group of patients. Understanding the disease process and
the impact of hypertensive disorders on pregnancy is of the utmost importance,
because these disorders remain a major cause of maternal and perinatal morbidity and
mortality worldwide.
As a health care provider, life modification and improvement of patients wellbeing in regardless of race, gender and age is our primary goal. In fact, giving
unfathomable care to the sick is not only our sole responsibility but promoting health,
preventing illness, and alleviating suffering are some of our various obligations we need
to carry out in order to meet clients needs. Basically, catering ones need is a fulfillment
and creates satisfaction that will be inculcated to our minds forever.
We had interest and choose the attention-grabbing case for its atypical trait. We
appreciate this case since it is rare and challenging to our part as a student nurse. We
apprehend that this case study requires critical thinking and scientific method which will
probably enable us relate our knowledge gained from our instructors and studying.
OBJECTIVES
GENERAL OBJECTIVE:
At the end of our two-week exposure in the Southern Philippines Medical Center
Gynecology ward, we will be able to come up with a case study regarding a patient who
has eclampsia. This covers learning additional knowledge on what eclampsia is all
about, what are the different types and causes of it, how the disease progresses and
manifests its signs and symptoms, how does it affect the patient and the significant
others. In return, we, as health care personnel, may impart health teaching regarding
maintenance of current health status, prevention of potential problems and promotion
family support and emotional support for the patients wellbeing.
SPECIFIC OBJECTIVES:
This case study is made to achieve the following reasons:
1. Establish rapport with our patient as well as her significant others to gain trust
and cooperation.
2. Collect significant information regarding our patients conditions as well as the
family history, past and present health history.
3. Thoroughly assess our patient in cephalocaudal manner .
4. Evaluate clients data according to the nursing and developmental theory.
5. Present the anatomy and physiology of the organs involved.
6. Trace the Pathophysiology of the disease process and its enduring
symptomatology
7. Review and interpret medical order and results of possible laboratory
examination that the client has undergone.
3
8. Identify the different signs and symptoms, as well as the presentation of its
etiology and contributing factors in the development of pyelonephritis for future
purpose.
9. Make effective nursing care plans that address the present and possible needs.
10. Present Drug study on the clients medication.
11. Present discharge plan for clients condition.
HEALTH HISTORY
Patient had headache for 1 week, after CS, BTL for fetal distress.
PATIENT PROFILE
Name: Barney
Sex: Female
Age: 35 years old
Status: Married
Address: Agdao, Davao City
Nationality: Filipino
Religion: Roman Catholic
Occupation: None
Birthdate: August 8, 1980
Mother: Edna
Father: Jaunito
Spouse: Marlot
Birth Place: Davao City
Chief Complaint: Seizures
GENOGRAM
Fathers side
Mothers Side
Grandfath
er
64, alive
Youngest
22, alive
Grandmother
50, alive
Patient
35
eclampsia
Youngest
2 weeks
Second
eldest
36, alive
2nd youngest
10 years
Grandfath
er
70, dead
Eldest
38, alive
2nd eldest
11 years
Grandmother
60, alive
Daughter
28, alive
Son
(husband
of the
patient)
35, alive
Eldest
14 years
Male
Female
Patient
DEVELOPMENTAL TASK
Ericksons Stage Theory
Conflict
Resolution or virtue
Age
Adulthood
26-64 years
Generativity vs
Stagnation
Care
Culmination in old
age
Caritas, Caring for
others and agape
empathy and concern
ASSESSMENT
Skin
She has an even skin tone to the rest of her body. Good skin turgor noted and warm to
touch.
Head
She has a normocephalic head ,she has a symmetrical facial features and her facial
movements are well coordinated. She has dark thick hair which are evenly distributed to
her clean scalp.
Eyes
Her pupils are symmetrically equal, has a brisk reaction to light and a uniform
accommodation.
Ears
Mild tenderness was noted upon palpation on both ears, hearing is present on both
ears.
Mouth
She has symmetrical lips. Moist and fair pinkish in color. Tongue is at midline able to
move accordingly.
Symmetrical expansion upon breathing. Clear breath sounds noted upon auscultation
she is not in any form of respiratory distress.
Heart and Central Vessels
Her heart sounds is regular upon auscultation. No abnormal pulsation and tenderness
noted on pulsation areas and carotid arteries.
Abdomen
She has a good skin integrity and symmetrically fair and round.
Extremities
Both her hands are normal with regular peripheral pulses on her extremities. She is able
to move her extremities accordingly. She has no spinal deformities with good skin
turgor. Skin discoloration not noted.
10
Renal System
The urinary system, also known as the renal system, consists of the kidneys,
ureters, bladder, and the urethra. Each kidney consists of millions of functional units
called nephrons.
Renin Angiotensin Aldosterone system.
When blood volume falls or blood flow to the kidneys decreases, juxtaglomerular cells in the
kidneys secrete renin into the bloodstream. In sequence, renin and angiotensin converting
enzyme (ACE) act on their substrates to produce the active hormone angiotensin II, which
raises blood pressure in two ways. First, angiotensin II is a potent vasoconstrictor; it raises
blood pressure by increasing systemic vascular resistance. Second, it stimulates secretion of
aldosterone, which increases reabsorption of sodium ions and water by the kidneys. The water
reabsorption increases total blood volume, which increases blood pressure.
Antidiuretic hormone. ADH is produced by the hypothalamus and released from the posterior
pituitary in response to dehydration or decreased blood volume. Among other actions, ADH
causes vasoconstriction, which increases blood pressure.
Atrial Natriuretic Peptide. Released by cells in the atria of the heart, ANP lowers blood
pressure by causing vasodilation and by promoting the loss of salt and water in the urine, which
reduces blood volume.
11
DEFINITION OF TERMS
1. Kidney -The kidneys are bean-shaped organs that serve several essential
regulatory roles in vertebrates.
2. Ureters- the duct by which urine passes from the kidney to the bladder or
cloaca.
3. Bladder - a membranous sac in humans and other animals, in which urine is
collected for excretion.
4. Urethra - the duct by which urine is conveyed out of the body from the bladder,
and which in male vertebrates also conveys semen
5. Nephrons - each of the functional units in the kidney, consisting of a glomerulus
and its associated tubule, through which the glomerular filtrate passes before
emerging as urine.
6. juxtaglomerular cells- (JG cells, or granular cells) are cells in the kidney that
synthesize, store, and secrete the enzyme renin.
7. Renin (angiotensinogenase) an enzyme that participates in the body's reninangiotensin aldosterone system (RAAS)also known as the renin-angiotensinaldosterone axisthat mediates extracellular volume (i.e., that of the blood
plasma, lymph and interstitial fluid), and arterial vasoconstriction. Thus, it
regulates the body's mean arterial blood pressure.
8. Angiotensin - is a peptide hormone that causes vasoconstriction and a
subsequent increase in blood pressure. It is part of the renin-angiotensin system,
which is a major target for drugs that lower blood pressure.
9. Aldosterone - a steroid hormone, "the main mineralocorticoid hormone
produced by the outer section (zona glomerulosa) of the adrenal cortex in the
adrenal gland.
10. Beta human chorionic gonadotrophin (beta-hCG) - Human chorionic
gonadotropin (hCG) is a hormone produced by the embryo following
implantation.
11. Circulation - The movement of blood through the body that is caused by the
pumping action of the heart.
12. Blood vessels- a tubular structure carrying blood through the tissues and organs;
a vein, artery, or capillary.
12
13. Blood - a bodily fluid in humans and other animals that delivers necessary
substances such as nutrients and oxygen to the cells and transports metabolic
waste products away from those same cells
14. Oxygen poor blood- deoxygenated blood
15. Oxygen rich blood- oxygenated blood
16. Arteries- any of the muscular-walled tubes forming part of the circulation system
by which blood (mainly that which has been oxygenated) is conveyed from the
heart to all parts of the body.
17. Capillaries - A capillary is an extremely small blood vessel located within the
tissues of the body, that transports blood from arteries to veins. Capillaries are
most abundant in tissues and organs that are metabolically active.
18. Blood viscosity - is the thickness and stickiness of blood. It is a direct measure of
the ability of blood to flow through the vessels.
13
19. ETIOLOGY
Doctors dont know what causes preeclampsia. The following explains how the
symptoms of preeclampsia can lead to eclampsia.
Preeclampsia can cause your blood pressure (the force of blood against the walls of
your arteries) to become high enough to damage your arteries and other blood vessels.
Damage to your arteries may restrict blood flow and produce swelling in the blood
vessels of your brain. If this swelling interferes with your brains ability to function,
seizures may occur
Proteinuria
Preeclampsia commonly affects kidney function. Protein in your urine, also known as
proteinuria, is a key sign of the condition. Your kidneys filter waste from your blood but
retain beneficial nutrients, such as protein, in the blood for redistribution to your body. If
the kidneys filters (glomeruli) sustain damage, protein can leak through these filters and
excrete into your urine.
14
PATHOPHYSIOLOGY
Predisposing
Nulliparity
Family History
Poor outcome of
previous pregnancy
Hydatid mole
Teen pregnancy
Age (>35 years old)
Gestational diabetes
Pre-eclampsia
S/S
Convulsions
BP(160/110)
Proteinuria
Oliguria
Elevated Serum
creatinine
(>1.2mg/dL)
Etiology
(UNKNOWN)
Precipitating
Lower socio-economic
status
Obesity
Nutrition
Dietary deficiency or
excess
15
Epigastric pain
Fetal growth
Contracted labor
16
eclampsia
If treated
If not treated
Good prognosis
Complications
placenta
abruption, liver
hematoma, DIC,
Stroke
death
17
PROGNOSIS
Most women will have good outcomes for their pregnancies complicated by
preeclampsia or eclampsia. Some women will continue to have problems with their
blood pressure and will need to be followed closely after delivery. About 25% of women
who have had eclampsia will have elevated blood pressure in a subsequent pregnancy,
and about 2% will also have eclampsia in subsequent pregnancies.
Most babies will do well. Babies born prematurely will usually stay in the hospital longer.
A rule of thumb is to expect the baby to stay in the hospital until their due date.
Unfortunately, a few women and babies experience life-threatening complications from
preeclampsia or eclampsia. Complications in babies are generally related to premature
delivery, and outcomes for both mothers and babies are significantly worse in
developing countries. The maternal mortality (death) rate from eclampsia in developed
counties ranges from 0% to 1.8% of cases. Most of the cases of maternal death are
complicated by a condition known as HELLP syndrome, which is characterized by
preeclampsia along with hemolytic anemia, elevated liver function tests (LFTs), and low
platelet count.
18
SYMPTOMATOLOGY
SIGNS AND
IF PRESENT
RATIONALE
SYMPTOMS
Convulsions
BP (160/110)
Oliguria
Proteinuria
Elevated serum
creatinine
(>1.2mg/dL)
21
MEDICAL TREATMENT
Generic name:
Metoprolol
Brand name:
Lopressor
Classification:
Dosage:
100mg
Route:
PO
Frequency:
TID
22
MECAHNISM OF ACTION
Unknown. A selective beta blocker that selectively blocks beta1 receptors; decreases
cardiac output, peripheral resistance, and cardiac oxygen consumption; and depresses
rennin secretion.
INDICATIONS
Hypertension
Acute MI
Angina Pectoris
CONTRAINDICATIONS
Hypersensitive to drug.
NURSING RESPONSIBILITIES
Monitor BP
Inform patient about the side effects and adverse effects of the medication.
23
Generic Name:
MgSO4
Route
PO
Dosage
6 doses
Frequency
q4
Classification: Therapeutic: mineral and electrolyte replacements/supplements.
Pharmacologic: minerals/electrolytes
Indications
Treatment/prevention of hypomagnesemia. Treatment of hypertension. Anticonvulsant
associated with severe eclampsia, pre-eclampsia, or acute nephritis. Unlabeled uses:
Preterm labor. Treatment of Torsade de pointes. Adjunctive treatment for
bronchodilation in moderate to severe acute asthma.
Mechanism of Action
Essential for the activity of many enzymes. Plays an important role in neurotransmission
and muscular excitability. Therapeutic Effects: Replacement in deficiency states.
Resolution of eclampsia.
Contraindications/Precautions
24
Nursing Management
Before
- Assess for contraindicatedconditions.
- Monitor knee-jerk reflex beforerepeated parenteral administration.
- Give as laxative as temporarymeasure.
- Reserve IV use in eclampsia forlife-threatening situations.
- Observe the 15 rights in drugadministration.
During
- Give IM route by deep IM injection.
- Monitor serum magnesium levels.
- Do not give oral MgSO4 with abdominal pain, nausea, or vomiting.- Do not administer
if knee-jerk reflexes are suppressed- Monitor bowel function.
After
- Arrange to discontinue administration as soon as levels are within normal limits and
desired clinical response is obtained.
- Discontinue if diarrhea or cramping occurs.
- Arrange for dietary measures, exercise and environmental control to return to normal
bowel activity.
- Report sweating, flushing, muscle tremors or twitching, inability to move extremities.
- Maintain urine output at a level of 100 mL every 4 hr during parenteral administration.
25
DIAGNOSTIC TEST
HEMATOLOGY
Hemoglobin
Result
L 63.0
Range
115.0 155.0 g/L
Hematocrit
L 0.23
0.36 0.48
RBC
L 3.86
WBC
H 10.42
MCV
L 58.80
79.40 94.80 fl
Interpretation
A low hemoglobin count is a
commonly seen blood test result.
Hemoglobin (Hb or Hgb) is a
protein in red blood cells that
carries oxygen throughout the
body.
In many cases, a low
hemoglobin count is only slightly
lower than normal and doesn't
affect how you feel. If it gets
more severe and causes
symptoms, your low hemoglobin
count may indicate you have
anemia.
Causes of low hematocrit, or
anemia, include: Bleeding
(ulcers, trauma, colon cancer,
internal bleeding) Destruction of
red blood cells (sickle cell
anemia, enlarged spleen)
Decreased production of red
blood cells (bone marrow
supression, cancer, drugs)
When the hemoglobin count is
low, the body is not able to get
as much oxygen to go
throughout the body.
An increased production of white
blood cells to fight an infection
Mean corpuscular volume (MCV)
is the average volume of red
cells in a specimen. MCV is
elevated or decreased in
accordance with average red cell
size; ie, low MCV indicates
microcytic (small average RBC
size), normal MCV indicates
normocytic (normal average
RBC size), and high MCV
26
MCHC
L 27.8
Neutrophil
H 79
55.00 75.00 %
Lymphocyte
L 16
20 35%
Monocyte
2 10 %
Eosinophil
1.000
18%
Differential
count
Basophil
Platelet Count
Urinalysis
Chemical Analysis
pH
319
Result
6.5
Range
an inflammatory response,
especially if an allergy is
involved.
Basophils are produced in your
bone marrow, circulate in the
blood and are the least abundant
of all leukocytes. They are
classified as immune cells and
categorized a granulocytes.
Therefore, the basic function of
this white blood cell is release of
its substances in response to a
foreign invasion.
A platelet count is a lab test to
measure how many platelets you
have in your blood. Platelets are
parts of the blood that help the
blood clot. They are smaller than
red or white blood cells.
Interpretation
A urine pH test can tell
your doctor how acidic
or basic (alkaline) your
urine is using a simple,
painless urine test.
Many diseases, your
diet, and the medicines
you take can affect
how acidic or basic
your urine is. For
instance, results that
are either too high or
low can indicate the
likelihood that your
body will form kidney
stones. If your urine is
at an extreme on either
the low or high end of
pH levels, you can
adjust your diet to
reduce the likelihood
painful kidney stones
28
Glucose
Negative
Protein
Negative
Urine
Flowcytometry
WBC
8.0
Leukocyte esterase is
an enzyme present in
most white blood cells
(WBCs). Normally, a
few white blood cells
(see microscopic
examination) are
present in urine and
this test is negative.
When the number of
WBCs in urine
increases significantly,
this screening test will
become positive.
When the WBC count
in urine is high, it
means that there is
inflammation in the
urinary tract or kidneys.
The most common
29
RBC
H 40
0 28 /uL
Epithelial Cells
H 14
0 7/uL
Cast
Bacteria
means.
Urinary casts are
formed only in the
distal convoluted
tubule (DCT) or the
collecting duct (distal
nephron). The proximal
convoluted tubule
(PCT) and loop of
Henle are not locations
for cast formation.
Hyaline casts are
composed primarily of
a mucoprotein (TammHorsfall protein)
secreted by tubule
cells.
Urine is normally
sterile, which means
that it contains no
bacteria. A small
number of bacteria
may be found in the
urine of many healthy
people. This is usually
considered to be
harmless. However, a
certain level of bacteria
can mean that the
bladder, urethra, or
kidneys are infected.
31
NCP
Assessment
Objective:
Hemoglobin :
68
Diagnosis
Activity
intolerance
related to
weakness
Planning
After 8 hours
of nursing
intervention
the patient will
be able to:
Report that
she is able to
ambulate
within the
room
Demonstrate a
decrease in
physiologic
signs of
intolerance
Intervention
Assess
patients ability
to do normal
tasks
To know
if the
patient
needs
assistan
ce
Evaluation
Patient reveals
an increase in
activity
tolerance
Demonstrating
a reduction on
physiologic
signs of
activity
intolerance
Note changes
in muscle
weakness
Recommend
bed rest and
quiet
atmosphere
Provide
assistance on
activities and
ambulation
when
necessary
Assessment
Objective:
Hemoglobin:
68
Diagnosis
Risk for
infection
related to
inadequate
secondary
defenses
(decreased
hemoglobin)
Planning
After 8 hours
of nursing
intervention
the patient will
be able to:
Identify
interventions
to prevent/
reduce risk for
infection
Intervention
Monitor VS
Obtain
appropriate
fluid
specimens for
observation
and culture
testing.
Evaluation
Verbalize
understanding
of instructions.
Observe for
localized signs
of infection
Instruct
patient to
wash hands
before eating.
32
33
DISCHARGE PLANNING
Medication
Exercise
Out-patient Order
Diet
35
RECOMMENDATIONS
As nurses, our vital role is to provide health care and deliver services in the
hospital to improve the health status of each individual. This nursing care study is
important for us because it in enables to give the proper health teaching to our chosen
client.
We recommended this case to the following persons and institution for the further
improvement of the study.
TO THE FAMILY:
This study for the family of our patient to follow the treatment prescribed such as
to take the medications as on time and right dosage and other recommended measures
by the physicians, encourage having adequate rest to hasten the recovery of the
patient. Through the adherence of fulfillment of the suitable medical management, for
the fast recovery of the patient.
TO THE STUDENT:
We recommended this study for the students as a reference for the future cases,
in order to have some based line datas to refer.
TO THE COLLEGE OF NURSING
We recommended this study to our department for giving us a precise details and
an access of further study of this case. We advocate also for giving us an abundance
time to research in order to prevent typographical and grammatical errors.
TO THE SOUTHERN PHILIPPINES MEDICAL CENTER
We recommended this study to Southern Philippines Medical Center for them to
able to evaluate and appreciate the said case and share this as a reference and
information having those patients who has certain condition.
36
BIBLIOGRAPHY/REFERENCES
1. Blackwells Nursing Dictionary Second Edition (2005), Blackwells Publishing Ltd.
2. Sibai, B.M. (2004) Pre-eclampsia: An inflammatory syndrome? American Journal
of Obstetrics and Gynecology, 191, 1061-1062. doi:10.1016/j.ajog.2004.03.042
3. Williams, K., Bianco Lim, K., Wilson, S., et al. (2004) Can clinical symptomology
predict maternal cerebral perfusion pressure in pre-eclampsia? Revista Chilena
de Obstetrica y Ginecologia, 69, 361-367..
4. Urassa, D.P., Carlstedt, A., Nystrom, L., Massawe, S.N. and Lindmark, G. (2006)
Eclampsia in Dar es Salaam, TanzaniaIncidence, outcome, and the role of
antenatal care. Acta Obstetrica et Gynecologica Scandinavica, 85, 571-578.
doi:10.1080/00016340600604880
5. Fundamentals of Nursing Eight Edition, Kozier&Erbs, Pearson, Prentice Hall
6. Nurses Pocket Guide, Diagnoses Prioritized Interventions, and
rationales,MarilynnE.Doenges,Mary Frances Moorhoouse,Alice C. Murr, 13 th
edition.
7. Lippincotts Nursing Drug Handbook, Lippincott, 2014
37